The Laboratory’s primary focus is the development of medical technology for treating cancer patients with accelerator based epithermal neutron sources for BNCT .

Main areas of research:

  • Preclinical and clinical conditions for effective and efficient effects of neutron flux on cancer cells;
  • Development of clinical protocols for the treatment of oncological patients with accelerator based epithermal neutron sources for BNCT;
  • Development of methods for the selective delivery of boron-10 to tumor cells.

The key research focus is preclinical testing of in vitro and in vivo mechanisms for treating glioma, breast, and melanoma tumors using accelerator based epithermal neutron sources for BNCT.

Laboratory activities also include:

  • Assessing the prospects for BNCT in oncology clinics;
  • Identification of conditions that support the safety and effective impact of neutron beams on tissues and human body systems by researching in vitro and in vivo.

The Laboratory conducts interdisciplinary research and collaborates with other NSU departments, and SB RAS institutes and institutions: Institute of Nuclear Physics
Institute of Cytology and Genetics
A.V. Nikolaev Institute of Inorganic Chemistry
Institute of Molecular and Cellular Biology